Our results showed that BRPF inhibition could serve as a promising strategy in taxane-resistant CR-PCa, and the mechanism of resensitization appears to involve the inhibition of drug efflux in cells that overexpress ABCB1. This evidence concerns the gene ABCB1 and posterior cortical atrophy.